Outcome and Predictive Factors of Radiation Therapy for Medulloblastoma: Mansoura Experience
Journal Title: Journal of Cancer and Tumor International - Year 2017, Vol 5, Issue 3
Abstract
Background: Medulloblastomas are the most common infratentorial malignant brain tumors with an incidence rate of 0.5 in 100.000 typically arising in childhood at age 5-9 years. Aim of Work: Exploring the epidemiological characteristics, treatment outcome and prognostic factors of medulloblastoma patients whom were referred to Mansoura Clinical Oncology &Nuclear Medicine Department for adjuvant treatment through the period from Jan. 1997 to Dec. 2011 inclusive. Patients and Methods: Sixty-Two patients records were in harmony with the eligibility criteria . Males were slightly larger in number [33 cases (53%)]. The majority of the cases were of pediatric age (42 patient representing 68%). Complete resection was possible in only 31 cases (50%).The classic type was the commonest [36 cases (58%)]. The majority were of the of M0 stage [52 cases (84%)] and of high risk category [37 cases (60%)]. Median dose to posterior fossa was 52.5 Gray (range, 43-56 Gray). The Chemotherapy was administrated in forty-seven patients (75.8%). The toxicity of treatment were graded according to the National Cancer Institute Common Terminology Criteria for Adverse Events (version 3.0). Results: Adjuvant Radiotherapy was generally well tolerated. The median overall survival time and median progression – free survival were 90 & 72 months respectively. Relapse was reported in 28 patients (45.16%).M staging, extensiveness of resection, hydrocephalus at presentation and time elapsed till radiotherapy all affected significantly the prognosis. Conclusion: In conclusion, this study highlights the effect of stage, completeness of surgery, and early initiation of adjuvant radiotherapy on the outcome.
Authors and Affiliations
Dina Abd El-Ghaffar, Mohammed Farouk Akl, Amal Halim, Mahfouz Eita
Keywords
Related Articles
- EP ID EP308951
- DOI 10.9734/JCTI/2017/33525
- Views 92
- Downloads 0
Significance of Tumor Marker CA15-3 in Metastatic Breast Cancer
Secondary spread of cancer to bones is commonest and frequent phenomenon and enhances the need of special care for sufferers. Bone metastases mostly are the first complication of different variety of cancers which increa...
MiRNA and Target Oncogene Regulation in Triple Negative Breast Cancer: An Age, Ethnic and Environmental Related Neoplastic Event
Triple-negative breast cancer is a type of aggressive breast cancer without the immunohistochemical expression of estrogen receptors, progesterone receptors and human epidermal growth factor receptor-2; with poor prognos...
Efficacy and Safety of Sorafenib in Patients with Advanced Hepatocellular Carcinoma
Aims: Advanced Hepatocellular carcinoma (HCC) is a major health problem with limited treatment options. The Sorafenib monothearpy is the only efficacious systemic treatment agent showing a survival benefit in these patie...
Leiomyosarcoma of the Kidney: Case Report and Brief Literature Review
Primary leiomyosarcoma of the kidney is a rare tumor with an aggressive behavior. However, reported literature is very limited. We report a case of renal leiomyosarcoma in a 46 years old woman presenting with a left side...
Assessment of Kirsten Sarcoma Viral Gene Mutations in Non-neoplastic and Neoplastic Nodular Lesions of Thyroid in Pakistan
Objectives: To assess KRAS mutations in non-neoplastic and neoplastic nodular lesions of thyroid as the incidence of KRAS mutations in thyroid lesions in Pakistan has not been evaluated. Methods: The cross sectional stu...